Dr. Sorensen
medical oncologist
Galera Therapeutics
New Zealand
Biography
Dr. Sorensen is President and Chief Executive Officer of Galera Therapeutics. Dr. Sorensen is a Medical Oncologist who has spent 7-8 years each in patient care (including his oncology fellowship at the Mayo Clinic), in academia (at the National Institutes of Health), in leadership positions in clinical development in the pharmaceutical industry (GlaxoSmithKline and Bayer), and as President & CEO of private venture-funded biotechs, including Ascenta Therapeutics and Galera Therapeutics. He also serves as Chairman of other biotech companies, including OncoFusion Therapeutics. At Ascenta, Dr. Sorensen raised approximately $100 million in private financing and venture debt and secured global and regional deals for its three programs. Operationally, in about five years, Ascenta advanced two unrelated preclinical programs into broad clinical testing, managed multiple clinical trials, and developed an R&D presence in China. Dr. Sorensen is an advisor to the Biomarkers Consortium of the National Institutes of Health.
Research Interest
medical oncologist
